Cargando…

Can CA-125 Predict Lymph Node Metastasis in Epithelial Ovarian Cancers in Turkish Population?

Objective. The role of single preoperative serum CA-125 levels in predicting pelvic or paraaortic lymph node metastasis in patients operated for epithelial ovarian cancer has been investigated. Methods. 176 patients diagnosed with epithelial ovarian carcinoma after staging laparotomy between January...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sudolmuş, Sinem, Köroğlu, Nadiye, Yıldırım, Gökhan, Ülker, Volkan, Gülkılık, Ahmet, Dansuk, Ramazan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984847/ https://www.ncbi.nlm.nih.gov/pubmed/24795494 http://dx.doi.org/10.1155/2014/492537

Ejemplares similares

Female sexual distress in infertile Turkish women
por: Aydın, Serdar, et al.
Publicado: (2015)

Development and Validation of Turkish Version of The Female Sexual Distress Scale-Revised
por: Aydın, Serdar, et al.
Publicado: (2016)

CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis
por: Wani, Abdul Majid, et al.
Publicado: (2008)

Predictive value of indicator of CA125 combined with D-dimer (ICD) for lymph node metastasis in patients with ovarian cancer: A two center cohort study
por: Zhang, Li, et al.
Publicado: (2022)

CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting
por: Shawn LyBarger, K., et al.
Publicado: (2022)

Oocyte vitrification for oncological and social reasons
por: Köroğlu, Nadiye, et al.
Publicado: (2023)

Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer
por: Ran, Chao, et al.
Publicado: (2021)

Validation of the Turkish version of European Organization for Research and Treatment of Cancer QLQ-OV28 ovarian cancer specific quality of life questionnaire
por: Akdemir, Yeşim, et al.
Publicado: (2020)

The Relations Between HSG Proven Tubal Occlusion, Stimulated Intrauterine Insemination and Pregnancy Rate
por: Yetkin Yıldırım, Gonca, et al.
Publicado: (2017)

CA125 in ovarian tumour tissue at second laparotomy.
por: Maughan, T. S., et al.
Publicado: (1989)

HE4, CA-125, and cystic ovarian mass
por: Wiwanitkit, Viroj
Publicado: (2012)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?
por: Topcu, Ramazan, et al.
Publicado: (2022)

The effect of CA125 on metastasis of ovarian cancer: old marker new function
por: Yuan, Qin, et al.
Publicado: (2017)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
por: Dong, Hong, et al.
Publicado: (2021)

Platelet Indices as the Predictor of Antibiotics Response in Surgical Wound Infections Following Total Abdominal Hysterectomy
por: Akça, Aysu, et al.
Publicado: (2019)

Ultrasonographic Appearances of Cervical Lymph Nodes in Healthy Turkish Adults Subpopulation: Preliminary Study
por: Okumuş, Özlem, et al.
Publicado: (2017)

Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
por: Weiland, Florian, et al.
Publicado: (2012)

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.
por: Canney, P. A., et al.
Publicado: (1985)

The Value of CA 125 and CA72-4 in Management of Patients with Epithelial Ovarian Cancer
por: Fayed, Salah T., et al.
Publicado: (1998)

Ovarian dysgerminoma with a metastasis to para‐aortic lymph node
por: Kawase, Rieko, et al.
Publicado: (2021)

Characteristics of total laparoscopic hysterectomy among women with or without previous cesarean section: retrospective analysis
por: Koroglu, Nadiye, et al.
Publicado: (2018)

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker
por: Sánchez Vega, Juan Fernando, et al.
Publicado: (2018)

Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
por: Mogensen, O., et al.
Publicado: (1990)

Pre-delivery fibrinogen level is a predictor for severity of placental abruption
por: Köroğlu, Nadiye, et al.
Publicado: (2023)

Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study
por: Ayhan, Ali, et al.
Publicado: (2018)

Intramammary lymph node metastasis in a patient with ovarian carcinoma and a brief review of the literature
por: Demir, Lutfiye, et al.
Publicado: (2012)

Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models
por: Yang, Bingyi, et al.
Publicado: (2016)

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer.
por: Rustin, G. J., et al.
Publicado: (1996)

Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer
por: Tcherkassova, Janneta, et al.
Publicado: (2011)

TB Peritonitis Mistaken for Ovarian Carcinomatosis Based on an Elevated CA-125
por: Boss, Joseph D., et al.
Publicado: (2012)

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
por: Rustin, G. J. S., et al.
Publicado: (2016)

Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
por: Chen, Zhixiang, et al.
Publicado: (2020)

Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer
por: Tang, Ying, et al.
Publicado: (2020)

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023)

Ligand-based adoptive T cell targeting CA125 in ovarian cancer
por: Zhao, Haihong, et al.
Publicado: (2023)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Ideal Lymph Node Number for Ovarian Malignancies
por: Karadağ, İbrahim, et al.
Publicado: (2022)

Evaluation of FGF-19 and β-klotho as biomarkers in patients with intrahepatic cholestasis of pregnancy
por: Tayyar, Ahter Tanay, et al.
Publicado: (2018)

Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors
por: Lertkhachonsuk, Arb‐aroon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5asg9ucatau1k86b79tn20uqhi